PEPTONIC medical AB (publ) (XSAT:PMED)
0.0600
0.00 (0.00%)
At close: Jan 31, 2024
PEPTONIC medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.63 | 0.2 | 3.74 | 15.13 | 3.57 | 10.15 |
Cash & Short-Term Investments | 0.63 | 0.2 | 3.74 | 15.13 | 3.57 | 10.15 |
Cash Growth | -90.49% | -94.79% | -75.29% | 324.40% | -64.88% | -74.17% |
Accounts Receivable | - | - | - | - | 7.24 | 5.17 |
Other Receivables | 1.42 | 7.02 | 2.74 | 6.37 | 0.93 | 1.62 |
Receivables | 1.42 | 7.02 | 2.74 | 6.37 | 8.18 | 6.79 |
Inventory | 5.26 | 5.62 | 4.99 | 16 | 15.55 | 10.32 |
Prepaid Expenses | 2.55 | 0.81 | 1.12 | 2.91 | 4.06 | 0.92 |
Total Current Assets | 9.85 | 13.64 | 12.59 | 40.42 | 31.35 | 28.19 |
Property, Plant & Equipment | 0.29 | 0.31 | 0.4 | 3.78 | 4.3 | 4.2 |
Goodwill | - | 3.3 | 4.46 | 5.63 | - | - |
Other Intangible Assets | 50.62 | 9.34 | 9.85 | 9.97 | 7.72 | 7.29 |
Long-Term Deferred Charges | - | 39.32 | 43.26 | 46.94 | 42.38 | 44.92 |
Other Long-Term Assets | - | 0 | - | - | 0 | - |
Total Assets | 60.76 | 65.92 | 70.56 | 106.74 | 85.75 | 84.6 |
Accounts Payable | 2.44 | 4.36 | 3.35 | 7.56 | 4.18 | 6.22 |
Accrued Expenses | 1.3 | 5.28 | 1.37 | 4.5 | 5.88 | 7.03 |
Short-Term Debt | 4.48 | 9.43 | 12.58 | 13.78 | 19.33 | 15.35 |
Current Income Taxes Payable | - | - | - | - | 0.24 | 0.19 |
Other Current Liabilities | 3.37 | 8.6 | 4.71 | 5.58 | 5.43 | 2.69 |
Total Current Liabilities | 11.59 | 27.67 | 22.01 | 31.41 | 35.07 | 31.48 |
Other Long-Term Liabilities | - | - | 0 | -0 | 3.6 | - |
Total Liabilities | 11.59 | 27.67 | 22.01 | 31.41 | 38.66 | 31.48 |
Common Stock | 2.07 | 42.95 | 40.32 | 38.37 | 24.27 | 19.16 |
Additional Paid-In Capital | 431.43 | 373.86 | 363.62 | 333.04 | 273.61 | 248.44 |
Retained Earnings | -384.56 | -378.57 | -355.82 | -301.47 | -258.19 | -224.1 |
Comprehensive Income & Other | 0.23 | 0 | 0.44 | 5.38 | 7.39 | 9.62 |
Shareholders' Equity | 49.18 | 38.25 | 48.55 | 75.32 | 47.09 | 53.12 |
Total Liabilities & Equity | 60.76 | 65.92 | 70.56 | 106.74 | 85.75 | 84.6 |
Total Debt | 4.48 | 9.43 | 12.58 | 13.78 | 19.33 | 15.35 |
Net Cash (Debt) | -3.86 | -9.23 | -8.84 | 1.36 | -15.77 | -5.19 |
Net Cash Per Share | - | -0.00 | -0.00 | 0.00 | -0.06 | -0.03 |
Filing Date Shares Outstanding | - | 9,337 | 9,337 | 1,535 | 242.74 | 191.64 |
Total Common Shares Outstanding | - | 9,337 | 5,759 | 1,535 | 242.74 | 191.64 |
Working Capital | -1.74 | -14.03 | -9.42 | 9 | -3.71 | -3.3 |
Book Value Per Share | - | 0.00 | 0.01 | 0.05 | 0.19 | 0.28 |
Tangible Book Value | -1.45 | 25.6 | 34.24 | 59.72 | 39.37 | 45.83 |
Tangible Book Value Per Share | - | 0.00 | 0.01 | 0.04 | 0.16 | 0.24 |
Machinery | - | 0.7 | 0.88 | 5.74 | 5.34 | 4.85 |